Desogestrel_Ethinyl_Estradiol: profile and news

Savient Pharmaceuticals, Inc. Announces Exploration of Strategic ...  Feb 17, 2006
Savient's product Mircette(R) (desogestrel/ethinyl estradiol and ethinyl estradiol), an oral contraceptive, is marketed by its licensee, Duramed Pharmaceuticals ... - Genetic Engineering News,

Cytogen and Savient Sign Letter of Intent for Marketing of ...  Feb 8, 2006
Savient's product Mircette® (desogestrel/ethinyl estradiol and ethinyl estradiol), an oral contraceptive, is marketed by its licensee, Duramed Pharmaceuticals ... - Yahoo! News (press release)

Cytogen and Savient Sign Letter of Intent for Marketing of ...  Feb 8, 2006
Savient's product Mircette(R) (desogestrel/ethinyl estradiol and ethinyl estradiol), an oral contraceptive, is marketed by its licensee, Duramed Pharmaceuticals ... - PR Newswire (press release),

Savient Pharmaceuticals Finalizes Agreement for the Settlement of ...  Dec 2, 2005
Kariva(R). Under the terms of the transaction Barr will acquire the exclusive rights to Organon's Mircette (Desogestrel/Ethinyl Estradiol) oral contraceptive ... - PharmaLive.com (press release),

Barr, Organon and Savient Finalize Mircette(R) Settlement and ...  Dec 1, 2005
...and its subsidiaries have finalized an agreement to acquire the exclusive rights to Organon's Mircette(R) (Desogestrel/Ethinyl Estradiol) oral contraceptive ... - Finanzen.net,

Organon to Settle Mircette Litigation with Duramed  Sep 12, 2005
Mircette® (desogestrel/ethinyl estradiol and ethinyl estradiol) provides an oral contraceptive regimen of tablets each containing 0.15 mg desogestrel (13-ethyl ... - Patent Baristas,

Barr, Organon and Savient Announce Letter of Intent Regarding ...  08 Sep 2005
...have entered into a non- binding Letter of Intent to acquire the exclusive rights to Organon's Mircette(R) (Desogestrel/Ethinyl Estradiol) oral contraceptive ... - Finanzen.net,